Woodline implements a fundamental equity investment strategy, represented by a tenured team of global industry specialists.
Investment Stage: Series B; Series C
Portfolio 4
| Date | Name | Website | Total Raised | Location |
| 20.06.2026 | Cuprum Met... | cuprummetals.com | $19.4M | United Sta... |
| 07.02.2026 | Skyryse | skyryse.com | $638M | United Sta... |
| 13.01.2026 | Mirador Th... | miradortx.com | $250M | United Sta... |
| 11.08.2025 | Equillium | equilliumbio.com | $50M | United Sta... |
Mentions in press and media 19
| Date | Title | Description |
| 23.06.2026 | Cuprum Metals Secures $19.4 Million: Revolutionizing Copper Extraction | Cuprum Metals secures $19.4 million in Series A funding. The Lundin Family Office led this significant round. Woodline Partners and BHP Ventures also participated. This capital fuels the commercial scaling of Cuprum’s patented leaching tech... |
| 23.06.2026 | Rapalogix Health Raises $20M in Series A Funding | Rapalogix Health, a Carlsbad, CA-based biotechnology company which specializes in longevity-based skin health, raised $20M in Series A funding. The round was co-led by Woodline Partners and GordonMD Global Investments LP. The company intend... |
| 20.06.2026 | Cuprum Metals Raises $19.4 Million To Scale Copper Extraction Technology | Cuprum Metals announced that it has raised $19.4 million in Series A funding. The round was led by the Lundin Family Office, with support from Woodline Partners and BHP Ventures. Cuprum Metals said the funding will support the scaling of it... |
| 18.06.2026 | Cuprum Metals raises $19.4M Series A to accelerate Copper Extraction Technology | WINTER PARK, Fla., June 18, 2026 /PRNewswire/ -- Cuprum Metals Inc., a Delaware-based technology company, today announced the close of a US$19.4M Series A funding round led by the Lundin Family Office, and supported by Woodline Partners and... |
| 18.06.2026 | Cuprum Metals Raises $19.4M in Series A Funding | Cuprum Metals Inc., a Winter Park, FL-based chemical manufacturing technology company, raised US$19.4M in Series A funding. The round was led by the Lundin Family Office, with participation from Woodline Partners and BHP Ventures. The compa... |
| 30.04.2026 | Eli Lilly blows past quarterly estimates, hikes outlook as Zepbound and Mounjaro sales skyrocket | Eli Lilly on Thursday reported first-quarter earnings and revenue that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro spikes. Lilly hiked its full-year sales outlook by $2 billio... |
| 07.02.2026 | Skyryse: $300+ Million Series C Raised At $1.15 Billion Valuation For Aviation Automation | Skyryse, an aviation automation company focused on simplified flight controls, said it raised more than $300 million in a Series C round, valuing the business at more than $1.15 billion. The company said it has now raised more than $605 mil... |
| 14.01.2026 | Mirador Therapeutics Secures $250M, Accelerates Precision Medicine | Mirador Therapeutics secured $250M in Series B funding. This propels their innovative precision medicine strategy. Total capital raised now exceeds $650M. The San Diego firm targets immune-mediated inflammatory and fibrotic diseases. Funds ... |
| 13.01.2026 | Mirador Raises $250M in Series B Funding | Mirador Therapeutics, a San Diego, CA-based clinical-stage precision medicine company developing new therapies for immune-mediated inflammatory and fibrotic diseases, raised $250M in Series B funding. Backers included T. Rowe Price Investme... |
| 11.01.2026 | Diagonal Therapeutics Secures $125M to Propel Innovative Antibody Therapies | Diagonal Therapeutics secured $125M Series B funding. This advances DIAG723, a first-in-class clustering antibody. It targets hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH). The Watertown biotech corre... |
Show more